Metraipolis › archive › dc_38ef2161e9dc

Curcumin in Atherogenic Dyslipidemia: Linking Preclinical Mechanistic Insights to Clinical Outcomes — Europe PMC PMID:42514349

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42514349
DOI
10.3390/nu18142279
License (as archived)
solo-consultazione
Archived
2026-10-18T08:17:28.708Z
SHA-256 of the archived text
e2ac5972ddaa41a10733b1ba6f376c80f137dfdf7e15ea874b4100c8fbada8ca
Stable URL of this page
https://metraipolis.com/documento/dc_38ef2161e9dc

How to cite

Curcumin in Atherogenic Dyslipidemia: Linking Preclinical Mechanistic Insights to Clinical Outcomes — Europe PMC PMID:42514349 — Europe PMC (en), https://europepmc.org/article/MED/42514349 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_38ef2161e9dc (Metraipolis archive dc_38ef2161e9dc, sha256 e2ac5972ddaa41a10733b1ba6f376c80f137dfdf7e15ea874b4100c8fbada8ca)
BibTeX
@misc{dc38ef2161e9dc,
  title = {Curcumin in Atherogenic Dyslipidemia: Linking Preclinical Mechanistic Insights to Clinical Outcomes — Europe PMC PMID:42514349},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42514349},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_38ef2161e9dc; sha256 e2ac5972ddaa41a10733b1ba6f376c80f137dfdf7e15ea874b4100c8fbada8ca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42514349. Agents can read the archived copy with the MCP tool read_document.